TY - JOUR
T1 - Nighttime hemodynamic phenotype. A novel risk factor for cardiovascular disease, especially heart failure
T2 - the practitioner-based nationwide JAMP study
AU - the JAMP Study Group
AU - Kario, Kazuomi
AU - Hoshide, Satoshi
AU - Mizuno, Hiroyuki
AU - Kabutoya, Tomoyuki
AU - Nishizawa, Masafumi
AU - Yoshida, Tetsuro
AU - Abe, Hideyasu
AU - Katsuya, Tomohiro
AU - Okawara, Yukie
AU - Kanegae, Hiroshi
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Non-dipper and riser patterns of nocturnal blood pressure (BP) are risk factors for cardiovascular disease (CVD), including heart failure (HF). However, the risk associated with a disrupted nocturnal pattern of heart rate is not well known. Objectives: To investigate whether the nighttime heart rate is a risk factor for HF, alongside nighttime BP phenotype. Methods: The practitioner-based, nationwide, prospective Japan Ambulatory Blood Pressure Monitoring Prospective (JAMP) study included patients with ≥ 1 CVD risk factor but without symptomatic CVD at baseline. All patients underwent 24-h ambulatory BP monitoring at baseline and were followed annually. Nocturnal heart rate dipping (%) was calculated as 100•[1 − nighttime/daytime heart rate]. Results: During a mean 4.5 years’ follow-up in 6,359 patients (mean age 68.6 years), there were 306 CVD events (119 stroke, 99 coronary artery disease, and 88 HF). A 10-beats/min increase in nighttime heart rate was significantly associated with a 36–47% increase in the risk of total CVD, stroke and HF events independently of office SBP and nighttime SBP (all p < 0.005). The CVD and HF risk associated with nocturnal heart rate dipping status was independent of office and 24-h systolic BP and nocturnal BP dipping status (p < 0.001). Performance of the final model for predicting HF including BP parameters was significantly improved by the addition of nocturnal heart rate dipping patterns (p = 0.038; C-statistic 0.852). Conclusion: Nighttime non-dipper and riser patterns of heart rate were associated with CVD especially HF, independently and additively of nocturnal BP dipping status, indicating the importance of antihypertensive strategies targeting nighttime hemodynamics. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000020377. Graphical abstract: [Figure not available: see fulltext.]
AB - Background: Non-dipper and riser patterns of nocturnal blood pressure (BP) are risk factors for cardiovascular disease (CVD), including heart failure (HF). However, the risk associated with a disrupted nocturnal pattern of heart rate is not well known. Objectives: To investigate whether the nighttime heart rate is a risk factor for HF, alongside nighttime BP phenotype. Methods: The practitioner-based, nationwide, prospective Japan Ambulatory Blood Pressure Monitoring Prospective (JAMP) study included patients with ≥ 1 CVD risk factor but without symptomatic CVD at baseline. All patients underwent 24-h ambulatory BP monitoring at baseline and were followed annually. Nocturnal heart rate dipping (%) was calculated as 100•[1 − nighttime/daytime heart rate]. Results: During a mean 4.5 years’ follow-up in 6,359 patients (mean age 68.6 years), there were 306 CVD events (119 stroke, 99 coronary artery disease, and 88 HF). A 10-beats/min increase in nighttime heart rate was significantly associated with a 36–47% increase in the risk of total CVD, stroke and HF events independently of office SBP and nighttime SBP (all p < 0.005). The CVD and HF risk associated with nocturnal heart rate dipping status was independent of office and 24-h systolic BP and nocturnal BP dipping status (p < 0.001). Performance of the final model for predicting HF including BP parameters was significantly improved by the addition of nocturnal heart rate dipping patterns (p = 0.038; C-statistic 0.852). Conclusion: Nighttime non-dipper and riser patterns of heart rate were associated with CVD especially HF, independently and additively of nocturnal BP dipping status, indicating the importance of antihypertensive strategies targeting nighttime hemodynamics. Clinical trial registration: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000020377. Graphical abstract: [Figure not available: see fulltext.]
KW - Cardiovascular disease
KW - Diurnal heart rate variability
KW - Heart failure
KW - Nighttime heart rate
KW - Nocturnal hemodynamics
UR - http://www.scopus.com/inward/record.url?scp=85133754718&partnerID=8YFLogxK
U2 - 10.1007/s00392-022-02051-w
DO - 10.1007/s00392-022-02051-w
M3 - Article
C2 - 35760927
AN - SCOPUS:85133754718
SN - 1861-0684
VL - 112
SP - 98
EP - 110
JO - Clinical Research in Cardiology
JF - Clinical Research in Cardiology
IS - 1
ER -